Akebia Therapeutics, Inc. (AKBA)

Last Closing Price: 1.35 (2026-03-09)

Weighted-Average Shares Outstanding (Diluted) (Annual)

Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.

Akebia Therapeutics, Inc. (AKBA) had Weighted-Average Shares Outstanding (Diluted) of 257.16M for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$236.20M
$-5.34M
$39.46M
$196.73M
$212.70M
$23.50M
$-27.22M
$-3.72M
$-3.72M
$-5.34M
$-5.34M
$-5.34M
$-5.34M
$23.50M
$24.77M
257.16M
Weighted-Average Shares Outstanding (Diluted)
257.16M
$-0.02
$-0.02
Balance Sheet Financials
$252.96M
$1.22M
$123.61M
$376.56M
$162.94M
$48.25M
$181.02M
$343.95M
$32.61M
$-26.43M
$32.61M
265.43M
Cash Flow Statement Financials
$67.99M
$-7.93M
$72.93M
$53.55M
$186.54M
$132.99M
$11.28M
--
--
Fundamental Metrics & Ratios
1.55
--
--
0.60
1.48
83.29%
9.95%
9.95%
10.49%
-1.58%
-2.26%
$67.87M
--
--
--
0.63
2.53
5.02
72.68
-16.39%
20.22%
-1.42%
-6.61%
$0.12
$0.26
$0.26